ONCOLOGY
cell counts Lung cancer can do a better prognosis and agencies ·
JANO.es March 23, 2011 12:34
. Measuring the number of circulating tumor cells may also help decide the most appropriate treatment and monitor response.
Cancer Scientists at Christie Hospital in Manchester (United Kingdom) ensure that the tumor cell count in patients with lung cancer can help determine the severity of the disease and decide the best treatment for each case.
This follows a study published in the latest issue of the Journal of Clinical Oncology, in which has counted the number of circulating tumor cells (CTC) in blood samples from a total of 101 lung cancer patients, taken before and after undergoing a course of chemotherapy.
Thus, they found that those with more than 5 CTCs in 7.5 ml of blood showed an overall survival of 4.3 months on average, about data "significantly worse" than those who had less than 5 CTC whose median survival was 8.1 months.
The results suggest that the counting of CTC could be an easy way to find out how a patient is responding to treatment within weeks of launch.
"Now we have to test this finding in more patients, but if the results are confirmed, it is possible to tailor treatments to individual patients and to find new ways to treat disease, "said Fiona Blackhall, author of the study.
JCO 2011; DOI: 10.1200/JCO.2010.28.7045
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Christie Hospital NHS Trust
The Christie - Home page
Journal of Clinical Oncology Journal of Clinical Oncology .
News Latest News - JANOes and agencies - the counting of lung cancer cells allows a better prognosis of the disease - JANO.es - ELSEVIER
0 comments:
Post a Comment